Form 4 for CVS CVS Health
Accepted 2023-04-04 00:00:00 ET · period of report 2023-04-01 · accession 0001127602-23-012242 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-04 | 2023-04-01 | CVS | Lynch Karen S | Pres, CEO, Dir | F - Tax | $74.31 | -93.7K | 112.9K | -45% | -$6.96M |
| D | 2023-04-04 | 2023-04-01 | CVS | Lynch Karen S | Pres, CEO, Dir | A - Grant | $74.31 | +245.0K | 245.0K | New | +$18.20M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-01 | F | D | 93,677 | $74.31 | 112,933 | D | — | — | (F1) Surrender of shares in payment of withholding taxes due upon the vesting and settlement of a performance stock unit award. |
| 2 | Derivative | Stock Option | 2023-04-01 | A | A | 244,952 | $74.31 | 244,952 | D | $74.31 · 2024-04-01 to 2033-04-01 | 244,952 Common Stock | (F9) Option becomes exercisable in four equal annual installments, commencing 4/1/2024. |